This report is the product of a journalistic investigation on clinical trials. It set out to identify ethical concerns in clinical trials that were conducted in India and used for approval of new drugs in the European Union (EU). It was initiated after discussions with the health advocacy organisation Wemos and the research organisation Centre for Research on Multinational Corporations (SOMO), both based in Amsterdam. Wemos has been campaigning with EU regulatory authorities to prevent the use of unethically conducted clinical trials towards marketing approval in the EU. The plan was to document available information on up to three trials and the ethical concerns that they raised.